Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
Masumi Ueda,Masumi Ueda,Masumi Ueda,Renato G. Martins,Renato G. Martins,Renato G. Martins,Paul C. Hendrie,Paul C. Hendrie,Paul C. Hendrie,Terry McDonnell,Jennie R Crews,Jennie R Crews,Tracy Wong,Brittany McCreery,Barbara Jagels,Aaron Crane,David R. Byrd,David R. Byrd,Steven A. Pergam,Steven A. Pergam,Steven A. Pergam,Nancy E. Davidson,Nancy E. Davidson,Nancy E. Davidson,Catherine Liu,Catherine Liu,Catherine Liu,F. Marc Stewart,F. Marc Stewart,F. Marc Stewart +29 more
Reads0
Chats0
TLDR
This Special Feature highlights the unique circumstances and challenges of cancer treatment amidst this global pandemic, and the importance of organizational structure, preparation, agility, and a shared vision for continuing to provide cancer treatment to patients in the face of uncertainty and rapid change.Abstract:
The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was reported on January 20, 2020, in Snohomish County, Washington. At the epicenter of COVID-19 in the United States, the Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, and University of Washington are at the forefront of delivering care to patients with cancer during this public health crisis. This Special Feature highlights the unique circumstances and challenges of cancer treatment amidst this global pandemic, and the importance of organizational structure, preparation, agility, and a shared vision for continuing to provide cancer treatment to patients in the face of uncertainty and rapid change.read more
Citations
More filters
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
Journal ArticleDOI
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
Jill R. Dietz,Meena S. Moran,Meena S. Moran,Steven J. Isakoff,Steven J. Isakoff,Scott H. Kurtzman,Shawna C. Willey,Harold J. Burstein,Harold J. Burstein,Richard J. Bleicher,Janice A. Lyons,Janice A. Lyons,Terry Sarantou,Paul L. Baron,Randy E. Stevens,Susan K. Boolbol,Benjamin O. Anderson,Benjamin O. Anderson,Lawrence N. Shulman,William J. Gradishar,Debra L. Monticciolo,Debra L. Monticciolo,Donna Plecha,Donna Plecha,Heidi Nelson,Katharine Yao +25 more
TL;DR: This Special Communication uses expert opinion of representatives from multiple cancer care organizations to categorize BC patients into priority levels (A, B, C) for urgency of care across all specialties and provides treatment recommendations for each of these patient scenarios.
Journal ArticleDOI
The Impact of the COVID-19 Pandemic on Cancer Patients.
TL;DR: This short review aims to focus on the impact of COVID-19 on a cancer patient and discuss management options and recommendation in addition to highlighting the currently available clinical guidelines and resources.
Journal ArticleDOI
COVID-19 and Cancer: a Comprehensive Review.
TL;DR: This comprehensive review discusses the impact of COVID-19 on health and the immune system of those affected, reviewing the latest treatment approaches and ongoing clinical trials and proposes potential approaches to manage this vulnerable population during this pandemic.
Journal ArticleDOI
Significant applications of virtual reality for COVID-19 pandemic.
TL;DR: Virtual Reality technology develops a platform to reduce the face to face interaction of doctors with the infected COVID-19 patients through live video streaming, which helps to improve surveillance systems on the ongoing situation.
References
More filters
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
First Case of 2019 Novel Coronavirus in the United States.
Michelle Holshue,Chas DeBolt,Scott Lindquist,Kathy H Lofy,John Wiesman,Hollianne Bruce,Christopher Spitters,Keith M. Marzilli Ericson,Sara Wilkerson,Ahmet Tural,George Diaz,Amanda C. Cohn,LeAnne Fox,Anita Patel,Susan I. Gerber,Lindsay Kim,Suxiang Tong,Xiaoyan Lu,Steve Lindstrom,Mark A. Pallansch,William C. Weldon,Holly M. Biggs,Timothy M. Uyeki,Satish K. Pillai +23 more
TL;DR: This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
Journal ArticleDOI
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Wenhua Liang,Wei-jie Guan,Ruchong Chen,Wei Wang,Jianfu Li,Ke Xu,Caichen Li,Qing Ai,Weixiang Lu,Hengrui Liang,Shiyue Li,Jianxing He +11 more
Journal ArticleDOI
Cancer treatment during COVID-19 pandemic.
TL;DR: Basic guideline in management of cancer patients during COVID-19 pandemic is provided, as cancer patients are immunocompromised and there are high chances of exposure during hospital visits and if they get infected, outcome can be fatal.
Journal ArticleDOI
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
Giuseppe Di Lorenzo,Rossella Di Trolio,Zisis Kozlakidis,Giuseppina Busto,Concetta Ingenito,Luciana Buonerba,Claudia Ferrara,Annamaria Libroia,Gianluca Ragone,Concetta dello Ioio,Beatrice Savastano,Mario Polverino,Ferdinando De Falco,Simona Iaccarino,Emilio Leo +14 more
TL;DR: The literature provides an inconclusive picture on potential preferred treatments for COVID-19 and their interactions with antineoplastic agents and future clinical trials are needed to better understand the interactions between different drugs in the context of CO VID-19 pandemic.
Related Papers (5)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu,Jennifer M. McGoogan +1 more
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more